Laura De Stefano
Impact in
-
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
-
- Multiple Myeloma Research and Treatments
Papers in
- Genetics 9
- Chronic Lymphocytic Leukemia Research 6
- Myeloproliferative Neoplasms: Diagnosis and Treatment 2
-
- Acute Myeloid Leukemia Research 2
- Chronic Myeloid Leukemia Treatments 1
- Co-authors
- Anna Grazia Recchia (11 shared papers)Sabrina Bossio (11 shared papers)Ernesto Vigna (11 shared papers)Massimo Gentile (11 shared papers)Fortunato Morabito (11 shared papers)L Botalla (2 shared papers)Antonio Liuzzi (2 shared papers)G. Oppizzi (2 shared papers)
- Journals
- Expert Opinion on Investigational Drugs (5 papers)Blood (2 papers)Chemotherapy (1 paper)Expert Opinion on Pharmacotherapy (1 paper)The Journal of Clinical Endocrinology & Metabolism (1 paper)
- Partner nations
- ItalySpainUnited States
In The Last Decade
Laura De Stefano
16 papers receiving 188 citations
Peers
Comparison fields: 5 of 52
- Genetics 55
- Hematology 40
- Endocrinology, Diabetes and Metabolism 25
- Immunology 31
- Pathology and Forensic Medicine 23
Countries citing papers authored by Laura De Stefano
This map shows the geographic impact of Laura De Stefano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura De Stefano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura De Stefano more than expected).
Fields of papers citing papers by Laura De Stefano
This network shows the impact of papers produced by Laura De Stefano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura De Stefano. The network helps show where Laura De Stefano may publish in the future.
Co-authors
The 25 scholars most cited alongside Laura De Stefano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 42 | |
| 2 | 1978 | 42 | |
| 3 | 1977 | 19 | |
| 4 | 2014 | 17 | |
| 5 | 2011 | 14 | |
| 6 | 2010 | 13 | |
| 7 | 2018 | 13 | |
| 8 | 2013 | 12 | |
| 9 | 2017 | 7 | |
| 10 | 2011 | 7 | |
| 11 | 2015 | 4 | |
| 12 | 2016 | 2 | |
| 13 | 2023 | 2 | |
| 14 | 2015 | 1 | |
| 15 | 2024 | 1 | |
| 16 | 2023 | 1 |
About Laura De Stefano
Laura De Stefano is a scholar working on Genetics, Hematology, Molecular Biology, Pathology and Forensic Medicine and Endocrinology, Diabetes and Metabolism, having authored 16 papers that have together received 197 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (6 papers), Acute Myeloid Leukemia Research (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Pituitary Gland Disorders and Treatments (2 papers), Chronic Myeloid Leukemia Treatments (1 paper), Glycosylation and Glycoproteins Research (1 paper) and Acute Lymphoblastic Leukemia research (1 paper). The work is most often cited by research in Genetics (55 citations), Hematology (40 citations), Endocrinology, Diabetes and Metabolism (25 citations), Immunology (31 citations) and Pathology and Forensic Medicine (23 citations). Laura De Stefano has collaborated with scholars based in Italy, Spain and United States. Frequent co-authors include Anna Grazia Recchia, Sabrina Bossio, Ernesto Vigna, Massimo Gentile, Fortunato Morabito, L Botalla, Antonio Liuzzi, G. Oppizzi, P. G. Chiodini and Lucio Morabito. Their work appears in journals such as Expert Opinion on Investigational Drugs, Blood, Chemotherapy, Expert Opinion on Pharmacotherapy and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.